Fig. 4.
Fig. 4. OX40L expression on donor T cells and regulation of GVHD lethality. / OX40L expression on donor T cells is not a potent regulator of CD4+ T-cell–mediated GVHD lethality. (A) Sublethally irradiated bm12 recipients (n = 8 per group per experiment) were given highly purified CD4+ T cells (105) from either 129/Sv OX40L−/− (○) mice or OX40L+/+(●) littermate controls, as indicated. Data from 2 replicate experiments with similar results are pooled. Groupwise comparisons revealed that P = .24. (B) Sublethally irradiated bm1 recipients (n = 5 per group) were given highly purified CD8+ T cells (1 or 3 × 106, as indicated in parentheses) from either 129/Sv OX40L−/− mice or OX40L+/+ littermate controls. No signficant differences were noted between relevant groups. (C) Antiasialo-GM1 antisera–pretreated BALB/c–SCID mice were given purified CD4+ T cells (106) from 129/Sv OX40L−/− (▵) mice or OX40L+/+ (▴) littermate controls (n = 5 per group). Survival was not improved in recipients receiving OX40L−/− versus OX40L+/+CD4+ T cells.

OX40L expression on donor T cells and regulation of GVHD lethality.

OX40L expression on donor T cells is not a potent regulator of CD4+ T-cell–mediated GVHD lethality. (A) Sublethally irradiated bm12 recipients (n = 8 per group per experiment) were given highly purified CD4+ T cells (105) from either 129/Sv OX40L−/− (○) mice or OX40L+/+(●) littermate controls, as indicated. Data from 2 replicate experiments with similar results are pooled. Groupwise comparisons revealed that P = .24. (B) Sublethally irradiated bm1 recipients (n = 5 per group) were given highly purified CD8+ T cells (1 or 3 × 106, as indicated in parentheses) from either 129/Sv OX40L−/− mice or OX40L+/+ littermate controls. No signficant differences were noted between relevant groups. (C) Antiasialo-GM1 antisera–pretreated BALB/c–SCID mice were given purified CD4+ T cells (106) from 129/Sv OX40L−/− (▵) mice or OX40L+/+ (▴) littermate controls (n = 5 per group). Survival was not improved in recipients receiving OX40L−/− versus OX40L+/+CD4+ T cells.

Close Modal

or Create an Account

Close Modal
Close Modal